122 - Intricacies of Joint Audits, Rx360, Supply Chain Security, and Networking in Pharma/MedTech with Jim Fries

Let's Combinate · 7 Feb 2024 · 35m

What this episode covers

Jim Fries, CEO of the nonprofit consortium Rx360, explains the mechanics and benefits of their joint audit program, which allows multiple pharmaceutical sponsors to share the cost of auditing a single supplier facility. He details how independent auditors conduct these reviews, how reports are licensed rather than shared openly, and how the model reduces the audit burden on suppliers while maintaining supply chain integrity. Fries also discusses the organization's evolution from its origins in the Hepburn contamination crisis to its current role in supply chain security, emphasizing the importance of member-driven working groups and relationship building.

Other shows on the same ground, closest first.

  • The Startup CPG Podcast · 27m

    R&D RADIO: How to Audit a Co-Packer: The Food QA's Hermi Galstian Explains

    Hermi Galstian, founder of The Food QA, explains to host Adam Yee how CPG founders can audit co-packers by distinguishing between food safety (preventing illness) and quality (consistency). She emphasizes that brands remain responsible for recalls and should verify manufacturers through third-party audits like SQF and BRC, as well as physical facility tours. Galstian details specific inspection points, including pest control, employee hygiene, equipment pre-op checks, and ingredient sourcing transparency, to mitigate risk.

  • Global Medical Device Podcast · 41m

    Auditing the Auditor

    Sara Adams, a Medical Device Guru at Greenlight Guru, explains the nuances of conducting and receiving audits, distinguishing between internal, supplier, notified body, and FDA inspections. She shares her experience managing approximately 25 audits annually at a previous contract manufacturing role and details how to negotiate findings by asking auditors to cite specific regulations. Adams emphasizes building a culture of quality where audits are viewed as opportunities for improvement rather than punitive checks, warning against treating quality management systems as static 'checkbox' exercises.

  • OnTrack · 14m

    Counterfeit Detection & Supply Chain Risks with Cofactr

    Phillip Gulley, co-founder of Cofactr, explains how his company operates as a supply chain risk management platform that integrates procurement, logistics, and rigorous counterfeit inspection. He details Cofactr’s physical handling of components, including 100% X-ray and LCR testing, to catch sophisticated counterfeits like mixed reels containing empty casings. The conversation highlights Cofactr’s deep integration with Altium 365, which pushes supply chain risk data back into the design environment, and their use of AI on AWS GovCloud to manage vendor communications and resolve partial deliveries.

  • The Startup CPG Podcast · 50m

    #257 Co-Man Due Diligence 101 with Riot Energy and Kelley Drye & Warren LLP

    Laura Jakobsen, founder of Riot Energy, and Daniella Carelli, Special Counsel at Kelley Drye & Warren LLP, discuss the critical importance of co-manufacturer due diligence and contract negotiation for CPG brands. They emphasize that a 'partnership approach' and transparent reporting on attainment, inventory, and yield loss are more valuable than low per-unit pricing. The conversation covers protecting trade secrets through fragmented ingredient sourcing, conducting effective facility walkthroughs, and the strategic advantage of brands drafting their own baseline contracts rather than redlining manufacturer templates.

  • Global Medical Device Podcast · 40m

    Navigating the Medical Device Single Audit Program (MDSAP)

    Danny Kroo, a medical device consultant and sub-contract lead auditor for registrars like BSI, joins Jon Speer and Etienne Nichols of Greenlight Guru to explain the Medical Device Single Audit Program (MDSAP). Kroo details how MDSAP consolidates regulatory audits for the US, Canada, Japan, Brazil, and Australia, noting that while it simplifies global market access, it has raised costs and barriers for small companies. He emphasizes that the audit is highly prescriptive, relying on a 231-page FDA 'Audit Approach' document, and warns that companies with immature quality systems often struggle with specific requirements like change control and internal auditor qualifications.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.